Stockreport

FDA Warning Puts ImmunityBio Anktiva Hopes And Valuation In Focus [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF FDA has issued a warning letter to ImmunityBio over allegedly misleading promotional materials for its bladder cancer therapy Anktiva. The letter raises concerns abou [Read more]